𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Protein kinase B modulates the sensitivity of human neuroblastoma cells to insulin-like growth factor receptor inhibition

✍ Scribed by Ana S. Guerreiro; Danielle Boller; Tarek Shalaby; Michael A. Grotzer; Alexandre Arcaro

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
710 KB
Volume
119
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The potential of the novel insulin‐like growth factor receptor (IGF‐IR) inhibitor NVP‐AEW541 as an antiproliferative agent in human neuroblastoma was investigated. Proliferation of a panel of neuroblastoma cell lines was inhibited by NVP‐AEW541 with IC~50~ values ranging from 0.15 to 5 μM. Experiments using an IGF‐IR neutralizing antibody confirmed that the IGF‐IR was essential to support growth of neuroblastoma cell lines. The expression levels of the IGF‐IR in individual neuroblastoma cell lines did not correlate with the sensitivities to NVP‐AEW541, while coexpression of the IGF‐IR and the insulin receptor (IR) correlated with lower sensitivity to the inhibitor in some cell lines. Intriguingly, high levels of activation of Akt/protein kinase B (PKB) and phosphorylation of the ribosomal S6 protein were observed in neuroblastoma cell lines with decreased sensitivities to NVP‐AEW541. Inhibition of Akt/PKB activity restored the sensitivity of neuroblastoma cells to the IGF‐IR inhibitor. Transfection of neuroblastoma cells with activated Akt or ribosomal protein S6 kinase (S6K) decreased the sensitivity of the cells to NVP‐AEW541. IGF‐I‐stimulated proliferation of neuroblastoma cell lines was completely blocked by NVP‐AEW541, or by a combination of an inhibitor of phosphoinositide 3‐kinase and rapamycin. In addition to its antiproliferative effects, NVP‐AEW541 sensitized neuroblastoma cells to cisplatin‐induced apoptosis. Together, our data demonstrate that NVP‐AEW541 in combination with Akt/PKB inhibitors or chemotherapeutic agents may represent a novel approach to target human neuroblastoma cell proliferation. © 2006 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Blockade of the insulin-like growth-fact
Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-II-mediated autocrine loop
✍ Harald Lahm; Paul Amstad; Josiane Wyniger; Aysim Yilmaz; Jürgen R. Fischer; Maga 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 930 KB

## Insulin -like growth factors (IGFs) are potent proliferation stimulators for numerous tumor cells and often function as autocrine growth factors. We have previously shown that exogenous IGF-I and IGF-II enhance proliferation of colorectal carcinoma cells. The biological signal of both factors i

Zinc partitions insulin-like growth fact
Zinc partitions insulin-like growth factors (IGFs) from soluble IGF binding protein (IGFBP)-5 to the cell surface receptors of BC3H-1 muscle cells
✍ Robert H. McCusker; Jan Novakofski 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

## Abstract Zinc (Zn^2+^) is a multifunctional micronutrient. The list of functions for this micronutrient expanded with the recent discovery that Zn^2+^ retains insulin‐like growth factors binding proteins (IGFBPs) on the surface of cultured cells, lowers the affinity of cell‐associated IGFBPs, an

Vitamin C suppresses proliferation of th
Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor II (IGF-II) production
✍ Seung Koo Lee; Jae Seung Kang; Da Jung Jung; Dae Young Hur; Jee Eun Kim; Eunsil 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

## Abstract Vitamin C plays a crucial role in the suppression of proliferation of several types of cancer. Over‐expression of cyclooxygenase (COX)‐2 and type I insulin‐like growth factor (IGF) receptor are important for proliferation and protection from apoptosis in malignancies. However, its speci